diabetic retinopathy glp 1 GLP-1 RA Weight Loss Drugs May Carry Untold Ocular Burden Updated guidance from the PCDS

SGLT2 Inhibitor and GLP-1 receptor agonist combination therapy substantially improved the renal function in a patient with type 2 diabetes: implications for additive renoprotective effects of the two drug classes

Any notable changes to energy, sleep, or mood

It also suppresses glucagon, a hormone that would otherwise raise blood sugar between meals

You can stay at the lower dose longer if you need time to adjust

We focus on what we do: coached strength training in a beginner-friendly environment where showing up and moving well is always enough

As obesity and insulin resistance are closely tied, this mechanism addresses root causes rather than symptomsmaking it especially valuable for patients with metabolic syndrome or prediabetes